The Alexandria Venture Investments-backed genetic disease therapy developer is floating above its range having increased the number of shares in the offering.

Alphabet, Telstra and RackSpace-backed endpoint cybersecurity technology producer CrowdStrike will float above a range it had already increased.

CyberAgent, GMO, Japan Post, Nikkei, Nippon Life, Recruit and Salesforce-backed Sansan priced its shares at the top of its range today and will raise $360m including the over-allotment option.

The Telstra and Telkom-backed enterprise messaging software provider priced its shares at the foot of the IPO's range but is in line to raise $32.5m when it floats next month.

Ideaya priced its shares below their range to raise $50m, providing exits for Alphabet, WuXi AppTec, Celgene, Roche and Novartis.

GlaxoSmithKline, Novartis and Astellas are among the investors to have celebrated an exit after cancer therapy developer Bicycle secured $60.7m in its initial public offering.

The O'Reilly Media, Deutsche Telekom and Swisscom-backed content delivery software provider floated at the top of its range and popped on its first day of trading.

Alexandria Real Estate Equities-backed Applied Therapeutics has gone public despite having to drastically cut its expectations for the offering.

Cortexyme has added $11.3m to its initial public offering, after the Pfizer, Takeda and Alphabet-based Alzheimer’s therapy developer raised $75m last week.

Motorola and JVC Kenwood-backed rugged electronics producer has floated below its range in a $39.6m offering, having previously raised some $117m in financing.